QSAM Biosciences, Inc. Annual report pursuant to Section 13 and 15(d)

STOCK OPTIONS (Tables)

12 Months Ended

Dec. 31, 2023

A summary of stock option activity and related information during the year ended December 31, 2023 is as follows:

SUMMARY OF STOCK OPTION ACTIVITY

	Options			Weighted Average Exercise Price		Weighted Average Remaining Contractual Term		Aggregate Intrinsic Value
Outstanding as of December 31, 2022		177,815		$	12.57		8.8	$	-
Expired (1)		(27,204	)	$	24.82		0	$	-
Granted		-		$	-		-	$	-
Outstanding as of December 31, 2023		150,611		$	10.35		7.84	$	-

(1)	27,204 options held by former employees and consultants of the Company were determined to be expired in 2023; however, their actual termination dates were prior to 2023.